Safety and efficacy of the Pipeline Flex embolization device with Shield Technology for the acute treatment of ruptured internal carotid artery pseudoaneurysms: a multi-institution case series
Neurosurgical Focus · 2023
DOI: 10.3171/2023.2.focus233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Focus, 2023. Verfasst von Michael T Bounajem und 25 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, Clinical Neuroscience Center, University of Utah, Salt Lake City, Utah. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Aneurysm, False, Embolization, Therapeutic, Thromboembolism. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE Ruptured blister, dissecting, and iatrogenic pseudoaneurysms are rare pathologies that pose significant challenges from a treatment standpoint. Endovascular treatment via flow diversion represents an increasingly popular option; however, drawbacks include the requirement for dual antiplatelet therapy and the potential for thromboembolic complications, particularly acute complications in the ruptured setting. The Pipeline Flex embolization device with Shield Technology (PED-Shield) offers reduced material thrombogenicity, which may aid in the treatment of ruptured internal carotid artery pseudoaneurysms. METHODS The authors conducted a multi-institution, retrospective case series to determine the safety and efficacy of PED-Shield for the treatment of ruptured blister, dissecting, and iatrogenic pseudoaneurysms of the internal carotid artery. Clinical, radiographic, treatment, and outcomes data were collected. RESULTS Thirty-three patients were included in the final analysis. Seventeen underwent placement of a single device, and 16 underwent placement of two devices. No thromboembolic complications occurred. Four patients were maintained on aspirin alone, and all others were treated with long-term dual antiplatelet therapy. Among patients with 3-month follow-up, 93.8% had a modified Rankin Scale score of 0–2. Complete occlusion at follow-up was observed in 82.6% of patients. CONCLUSIONS PED-Shield represents a new option for the treatment of ruptured blister, dissecting, and iatrogenic pseudoaneurysms of the internal carotid artery. The reduced material thrombogenicity appeared to improve the safety of the PED-Shield device, as this series demonstrated no thromboembolic complications even among patients treated with only single antiplatelet therapy. The efficacy of PED-Shield reported in this series, particularly with placement of two devices, demonstrates its potential as a first-line treatment option for these pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Neurosurgery, Clinical Neuroscience Center, University of Utah, Salt Lake City, Utah.
- 2Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- 3Department of Neurosurgery, Emory University, Atlanta, Georgia.
- 4Morehouse School of Medicine, Atlanta, Georgia.
- 5Department of Endovascular Surgical Neuroradiology/Neuroendovascular Surgery, University of Texas Southwestern Medical School, Dallas, Texas.
- 6Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin.
Zitieren
APA
Bounajem, M. T., Joyce, E., Scoville, J. P., Seinfeld, J., Hoffman, J., Grossberg, J. A., Waiters, V., White, A. C., Nerva, J., Burkhardt, J. K., Tonetti, D. A., El Naamani, K., Gooch, M. R., Jabbour, P., Tjoumakaris, S., Ortega Gutierrez, S., Levitt, M. R., Lang, M., Ares, W. J., …, & Grandhi, R. (2023). Safety and efficacy of the Pipeline Flex embolization device with Shield Technology for the acute treatment of ruptured internal carotid artery pseudoaneurysms: a multi-institution case series. Neurosurgical Focus. https://doi.org/10.3171/2023.2.focus233
Vancouver
Bounajem MT, Joyce E, Scoville JP, Seinfeld J, Hoffman J, Grossberg JA, et al. Safety and efficacy of the Pipeline Flex embolization device with Shield Technology for the acute treatment of ruptured internal carotid artery pseudoaneurysms: a multi-institution case series. Neurosurgical Focus. 2023. doi:10.3171/2023.2.focus233
BibTeX
@article{Bounajem2023,
author = {Bounajem, Michael T and Joyce, Evan and Scoville, Jonathan P and Seinfeld, Joshua and Hoffman, Jessa and Grossberg, Jonathan A and Waiters, Vanesha and White, Andrew C and Nerva, John and Burkhardt, Jan-Karl and Tonetti, Daniel A and El Naamani, Kareem and Gooch, M Reid and Jabbour, Pascal and Tjoumakaris, Stavropoula and Ortega Gutierrez, Santiago and Levitt, Michael R and Lang, Michael and Ares, William J and Desai, Sohum and Mascitelli, Justin R and Kilburg, Craig J and Budohoski, Karol P and Couldwell, William T and Gross, Bradley A and Grandhi, Ramesh},
title = {Safety and efficacy of the Pipeline Flex embolization device with Shield Technology for the acute treatment of ruptured internal carotid artery pseudoaneurysms: a multi-institution case series},
journal = {Neurosurgical Focus},
year = {2023},
doi = {10.3171/2023.2.focus233}
}
EUVIMED